• 한국수학교육학회지시리즈D:수학교육연구
• /
• 제27권2호
• /
• pp.175-193
• /
• 2024

In K-12 education, reassessment is a common practice, providing students with opportunities to enhance their understanding through low-stakes assignments. However, reassessment is underutilized in higher education, including during the challenges posed by the COVID-19 pandemic. Our study advocates for expanding the use of reassessment in university settings to promote holistic learning and focus on what shifts of change were made by students in an initial mathematics content course as they sought to gain licensure for teaching in a birth (daycare/pre-K setting) to eighth-grade classrooms. Our study took place during COVID-19 semesters and aimed to examine how using a reassessment approach early on in a gateway course for Prospective Teachers (PTs) affected the pass rate of the course. Results showed significant differences between the PTs who engaged with the test recovery and those who did not. We propose recovery opportunities like ours provide the necessary guidance to support early degree necessary classes that are typically gatekeeping and, as another, likely cause too few students within the courses because they were able to advance into the teacher pipeline and out into the field. Future studies may consider how the reassessment could be done more before the official summative assessment of a unit or chapter to continue the shifts in teaching practices and pedagogy that are constant within the K-12 education systems at the university level.

• 응용통계연구
• /
• 제32권5호
• /
• pp.741-752
• /
• 2019

제1상 임상시험의 주목적은 최대허용용량(maximum tolerated dose; MTD)을 결정하는 것이다. MTD 결정을 통해 다음 임상시험에 사용될 용량이 제한되므로 투약용량 발견 시험이라고도 불리며 매우 중요한 단계이다. MTD를 결정하는 방법에는 대표적으로 DM 방법, SM 방법, CRM 방법이 있다. 본 논문에서는 기존 수정된 CRM 방법에 초기가속화 단계를 적용하여 낮은 용량에 다수의 피험자가 할당되는 문제점을 보완하는 새로운 MTD 추정 방법을 제안하였고 기존 방법들과의 비교를 위해 모의실험을 실시하였다.

• 응용통계연구
• /
• 제15권2호
• /
• pp.323-336
• /
• 2002

최근에 1상 임상실험 에서 사용되는 continual reassessment method (CRM)에 대한 연구가 활발히 이루어지고 있다. 본 논문에서는 세 명의 환자를 하나의 환자 군으로 삼아 동일한 용량을 투여하는 수정된 CRM에 대한 연구를 실행하였다. 지금까지 CRM에 대한연구는 대부분 시뮬레이션에 의존하여 왔지만, 본 논문에서는 모든 가능한 경우를 고려하는 방법(complete enumeration)을 사용하였다. 이 새로운 방법은 시뮬레이션을 대체할 유용한 방법이라 사료된다. 이 새로운 방법을 이용하여, 용량독성곡선이 logistic함수, hyperbolic tangent 함수, power 함수일 때, 수정된 CRM에서 결정한 최대허용용량에서의 독성 확률이 목표 독성 확률로 잘 수렴함을 보였다. 하지만, 실험 전에 용량들을 적절히 선택하지 못하면, 최대허용용량에서의 독성 확률이 목표 독성 확률과 상당한 차이를 낼 수도 있음을 발견하였다.

• 대한기계학회논문집B
• /
• 제20권12호
• /
• pp.3926-3937
• /
• 1996

In recent years there has been increased interest in the continuum model associated with the solidification of binary mixtures. A review of the literature, however, shows that the model verification was not sufficient or only qualitative. Present work is conducted for the reassessment of continuum model on the solidification problems of binary mixtures widely used for model validation. In spite of using the same continuum model, the results do not agree well with those of Incropera and co-workers which are benchmark problems typically used for validation of binary mixture solidification. Inferring from the agreement of present results with the analytic, experimental and other model's numerical results, this discrepancy seems to be caused by numerical errors in applying continuum model developed by Incropera and co-workers, not by the model itself. Careful examination should be preceded before selecting validation problems.

• 응용통계연구
• /
• 제27권1호
• /
• pp.13-20
• /
• 2014

제 1상 임상시험의 목적은 피험자가 견딜 수 있는 최대의 용량인 최대허용용량(Maimum Tolerated Dose; MTD)을 추정하는 것이다. 최대허용용량을 추정하는 방법으로는 SM방법, ATD방법, CRM방법 등이 있다. 본 연구에서는 제 1상 임상시험에서 멈춤규칙을 이용한 최대허용용량 추정법을 제안하였다. 제안한 최대허용용량 추정법은 연속재평가방법(Continual Reassessment Method; CRM)과 모의실험을 통해 비교하였다.

• Animal cells and systems
• /
• 제7권3호
• /
• pp.191-196
• /
• 2003

Taxonomic confusion has been presented within freshwater crayfishes of the genus Cambaroides since Starobogatov published morphological definition and revision of the group in 1995. He suggested that Cambaroides should be revised: the C. dauricus, contained three species C. dauricus, C. wladiwostokiensis, and C. koshewnikowi; the C. schrenckii with two. species C. schrenckii and C. sachalinensis. Also Straovogatov did not take into account the previous data. of crayfish distributions. In order to. clear up the confusion, the taxonomy of crayfish sampled from Mongolia, Russia, China, and North Korea was reassessed. Starovogatov's key could not lead to the correct identification. Also, detailed observations of apical robe of the male first pleopod did not support the taxonomy on the genus Cambaroides proposed by Starobogatov in 1995. However, some local variations of morphology exist in rostrum, pleuron, and telson of Asian crayfish. Future studies should be concentrated on whether there are geographical clines of morphology or if taxonomic subdivision is necessary.

• Journal of the Korean Statistical Society
• /
• 제32권1호
• /
• pp.33-46
• /
• 2003

The continual reassessment method (CRM) provides a Bayesian estimation of the maximum tolerated dose (MTD) in phase I clinical trials. The CRM has been proposed as an alternative design of the standard design. The CRM has been modified to improve practical feasibility and, recently, the likelihood approach CRM has been proposed. In this paper we investigate the consistency and asymptotic normality of the modified likelihood approach CRM in which the maximum likelihood estimate is used instead of the posterior mean. Small-sample properties of the consistency is examined using complete enumeration. Both the asymptotic results and their small-sample properties show that the modified CRML outperforms the standard design.

• Korean Journal of Otorhinolaryngology-Head and Neck Surgery
• /
• 제61권12호
• /
• pp.658-662
• /
• 2018

Background and Objectives The early assessment of treatment is not done for benign paroxysmal positional vertigo (BPPV) since the well-known phenomenon of fatigability after a repeated positional test can mimic successful treatment. The aim of this study is to evaluate the clinical implication of 'fatigability' after Epley maneuver and to identify the therapeutic efficacy of Epley maneuver in posterior canal BPPV (PC-BPPV). Subjects and Method This study was prospectively conducted by two dizziness clinics on 51 consecutive patients diagnosed with PC-BPPV. All patients included in the study received Epley maneuver treatment. The therapeutic results were reassessed immediately after a single trial of Epley maneuver. After 30 minutes, results were reassessed repeatedly to confirm the fatigability of diagnostic procedure immediately after treatment. If the treatment was not successful after 30 minutes, Epley maneuver was repeatedly performed until complete resolution. Results Immediately after the first maneuver, 45 of 51 (88.2%) patients had neither vertigo nor nystagmus during the positional test. All patients demonstrated complete resolution after receiving one to three Epley maneuvers on the day of diagnosis. 'Fatigability (false negative result)' was confirmed for only one case (1 of 6 patients, 16.7%), in which nystagmus was observed after 30 minutes but not identified immediately after the first Epley maneuver. Conclusion The therapeutic efficacy of Epley maneuver is very high in PC-BPPV. Considering the possibility of fatigability when reassessment is performed immediately after therapeutic maneuver, clinicians should avoid assessing the outcome immediately after treatment in patients with PC-BPPV.

• 대한한방소아과학회지
• /
• 제37권3호
• /
• pp.35-48
• /
• 2023

Objectives We aimed to analyze changes in growth indicators before and after Korean medicine treatment in patients treated at the pediatric department of a hospital. Methods We analyzed the medical records of children and adolescents under 18 years of age who underwent growth assessment between January 1, 2017 and December 31, 2022. Results A total of 21 patients were selected for this study. After treatment, there was a significant increase in the height percentile, whereas bone age-chronological age (BA-CA) and predicted adult height (PAH) did not show significant changes. No major adverse reactions were observed during the treatment. Growth reassessment was conducted twice for 10 participants. When comparing the growth indicators between the assessment sessions, the height percentile showed an increasing trend between the initial and the first growth reassessment. However, there were no significant differences between BA-CA and PAH across the different assessment periods. Conclusions There is a need to establish evidence for the efficacy and safety of continuous Korean medicine growth treatment through the long-term observation of growth indicators in patients undergoing treatment for two or more periods, as well as observational studies on liver and renal function indicators.

• 천문학회보
• /
• 제33권1호
• /
• pp.36.2-36.2
• /
• 2008